Renaissance Technologies CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 230 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Renaissance Technologies ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$28,566
+295.0%
2,226,512
+115.8%
0.04%
+344.4%
Q2 2022$7,232
+147.1%
1,031,612
+192.1%
0.01%
+200.0%
Q1 2022$2,927
+2.2%
353,112
-16.5%
0.00%
-25.0%
Q4 2021$2,863
+933.6%
422,886
+709.5%
0.00%
Q3 2021$277
-90.3%
52,238
-92.9%
0.00%
-100.0%
Q1 2020$2,846
+331.9%
739,226
+320.7%
0.00%
+200.0%
Q4 2019$659
+14.2%
175,700
+15.0%
0.00%0.0%
Q3 2018$577
-84.7%
152,722
-90.1%
0.00%
-50.0%
Q2 2018$3,778
+13.8%
1,535,966
+10.5%
0.00%
-50.0%
Q1 2018$3,321
-23.8%
1,389,500
+24.7%
0.00%
-20.0%
Q4 2017$4,356
+197.1%
1,114,100
+91.6%
0.01%
+150.0%
Q3 2017$1,466
-40.4%
581,600
-34.8%
0.00%
-33.3%
Q2 2017$2,461
+229.9%
891,800
+133.2%
0.00%
+200.0%
Q1 2017$746
+4562.5%
382,400
+2449.3%
0.00%
Q3 2016$16
-92.2%
15,000
-91.5%
0.00%
Q1 2016$206
+123.9%
175,800
+728.2%
0.00%
Q1 2015$92
-85.9%
21,227
-89.2%
0.00%
-100.0%
Q3 2014$652
+54.5%
196,500
+41.9%
0.00%
+100.0%
Q3 2013$422138,5000.00%